Embody NAD+ review
Claims outrun the evidence
A $99 NAD⁺ injection sold behind a lander headed "Start Aging Backwards" — the price is real, the claims are not.
Our verdict
Embody's NAD⁺ line is priced competitively and dispensed transparently: $99 a month flat under a running sale, four named compounding pharmacies, LegitScript certification, and the telehealth visit, prescription and shipping included with no membership. What sits on top of that is the problem. The lander is headed "Start Aging Backwards", calls NAD⁺ the fountain-of-youth peptide, and lists "scientifically proven to help you feel younger, sharper and more alive", "revitalize cellular DNA" and "rejuvenate youthful skin" among its benefits. None of that is supported by controlled human evidence. Injected NAD⁺ has no controlled outcome trials at all; the randomized work sits with the oral precursors NR and NMN, and even there the endpoint reached is a raised blood NAD⁺ level, not a demonstrated clinical benefit. Buy it on price and disclosure, and discount the copy entirely.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- NAD⁺ telehealth
- Access
- NAD⁺ 500mg–1000mg injection advertised at $99/mo flat under a $100-a-month summer sale; visit included, free shipping
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- All 50 states claimed
- LegitScript
- Claimed by provider
- Updated
- September 2026
Sponsored alternative
Enhance MD
Physician-supervised NAD⁺ under lab-guided oversight
Check Enhance MD availability →What it is
The NAD⁺ line of Embody (Modern Metabolic Medicine, Inc., trading as Em), sold through a dedicated lander at nad.joinem.co rather than through the company's main store — its main Shopify catalog carries only semaglutide and tirzepatide, so the longevity products are reachable only through their own funnels. This page covers the NAD⁺ product specifically; Embody's sermorelin line is reviewed separately, because the two are sold as separate products with separate landing pages and separate pricing.
How it works
Asynchronous. A free online medical evaluation is reviewed by a licensed provider, and if appropriate the prescription is filled by one of four named compounding pharmacies and shipped. The telehealth visit, the prescription and shipping are stated to be included in the monthly price, with no membership fee layered on top — which is a cleaner structure than the membership models several competitors on this board use. Embody names its pharmacy partners, which is genuine dispensing transparency and rarer than it should be. ⚠ The site claims all 50 states but publishes no list, and the lander states no bloodwork is required — worth pausing on for a product marketed on cellular and metabolic effects.
Pricing transparency
NAD⁺ injections at 500mg–1000mg are advertised at $99 a month flat, with the telehealth visit, prescription and free shipping included and no membership. ⚠ Read the $99 as a promotional rate, not a standing one: it is created by a $100-a-month sale running on the lander, so the underlying rate is roughly double. Buyers have disputed how durable the advertised price lock is. Against this board, $99 promotional is competitive but not exceptional — Bayan Health publishes $99 as a standing price, Mondae is $93 on a three-month plan and $129 month-to-month, and Magnolia is $135, while Nex Gen sits at $299.
Branded vs compounded
Compounded NAD⁺ for injection, at 500mg–1000mg. Embody states that compounded medications are not FDA-approved, which is correct and properly placed. On the evidence, the gap between what is sold and what is claimed is the story of this page. Injected NAD⁺ has no controlled human outcome trials. The randomized human data in this area belongs to the oral precursors — nicotinamide riboside and nicotinamide mononucleotide — which reliably raise blood NAD⁺ levels, but where the endpoint reached in trials is that raised level rather than any demonstrated clinical outcome. So "scientifically proven to help you feel younger, sharper and more alive", "revitalize cellular DNA" and "rejuvenate youthful skin" are not supported claims for any NAD⁺ product, and are especially unsupported for the injected route this page sells.
Pros and watch-outs
What we like
- $99/month advertised flat, with the telehealth visit, prescription and shipping included
- No membership fee stacked underneath the medication price
- Four compounding pharmacies named — real dispensing transparency
- LegitScript seal displayed, and compounded status disclosed correctly
- Sold as its own product with its own lander, so the price is unambiguous
Watch-outs
- The lander's claims are not supported by controlled human evidence, and several are flatly wrong
- $99 is a sale price created by a $100-a-month discount, not a standing rate
- No bloodwork required, on a product marketed for cellular and metabolic effects
- All 50 states claimed with no list published
- Injected NAD⁺ is the route with the weakest evidence, and the page implies the opposite
Best for
Readers comparing injectable NAD⁺ purely on price and dispensing transparency, who can disregard marketing copy entirely.
Who should look elsewhere
Anyone choosing a longevity product on the strength of its evidence, or who wants baseline bloodwork before starting.
The evidence behind what Embody NAD+ prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How Embody NAD+ compares
A few alternatives worth a look, depending on what you’re optimizing for.
Embody
A low advertised sermorelin rate, if you treat the promo as a promo rather than a permanent price
See Embody →- Bayan Health
Readers who want a microdose entry point and their lab work priced in the same catalog
See Bayan Health →
MondaeBuyers who want a low, honest month-to-month price with the compounding source named
See Mondae →
More NAD⁺ telehealth reviews: Kin MedsKongoLaSara Medical GroupLevelUp RxLevers HealthLiberty
Research & data · Reviewed and last verified September 2026
How we assessed this. This review reflects Aminoscope’s own read of Embody NAD+’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is NAD⁺ really "scientifically proven" to make you feel younger?
- No. That phrase appears on Embody's own NAD⁺ lander alongside "revitalize cellular DNA" and "rejuvenate youthful skin", and none of it is supported. Injected NAD⁺ has no controlled human outcome trials. The randomized evidence in this area is for the oral precursors nicotinamide riboside and NMN, and what those trials demonstrate is a raised blood NAD⁺ level — a biomarker — rather than any clinical benefit like feeling younger or sharper. A page headed "Start Aging Backwards" is making a claim the science does not currently support in any form.
- Is the $99 a month price real?
- It is the advertised price, but it is a sale price. The lander runs a promotion taking $100 a month off, which puts the underlying rate at roughly double, and buyers have disputed how long the advertised lock actually holds. Treat $99 as promotional and ask what the standing rate is before subscribing. For comparison on this board, Bayan Health publishes $99 as a standing price for NAD⁺ injection and Mondae charges $129 month-to-month.
- Why is Embody's NAD⁺ reviewed separately from its sermorelin?
- Because Embody sells them as separate products, on separate landing pages, with separate pricing — its main store carries only semaglutide and tirzepatide, and each longevity product lives in its own funnel. We follow the seller's own structure: this page covers the NAD⁺ product and its lander, and Embody's sermorelin line has its own review. The company facts — four named pharmacies, LegitScript, the promotional pricing pattern — apply to both.
- Should I choose injectable NAD⁺ or an oral precursor?
- If the evidence base is what you are optimizing for, the oral precursors are the only ones with randomized human data behind them, and even they demonstrate a raised blood level rather than a clinical outcome. Injected NAD⁺, which is what this product is, has no controlled human outcome trials. The injectable route is often marketed as superior on absorption grounds; that is a pharmacokinetic argument, not an outcome one, and no seller on this board has trial evidence showing the injection produces a better result.
- Does Embody require bloodwork before prescribing?
- No — the lander states a free online medical evaluation with no bloodwork required. For a product sold on cellular energy and metabolic claims, that is worth noticing: there is no baseline measured, and so no way to demonstrate a change against one. It is the same gap we flag on Embody's sermorelin line, where a growth-hormone-axis product is prescribed without an IGF-1 baseline.
- Is Embody NAD+ legit?
- Embody NAD+ is an NAD⁺ telehealth service you reach through an online intake a clinician reviews. Its stated availability: All 50 states claimed. What it publishes up front: NAD⁺ 500mg–1000mg injection advertised at $99/mo flat under a $100-a-month summer sale; visit included, free shipping. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: a single monthly price you can check before an intake and which medications it dispenses. Ask for those in writing before you pay.